Security key
04272N102
ArriVent BioPharma, Inc. - Common Stock (AVBP)
CUSIP: 04272N102
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 25,909,614
- Total 13F value
- $612,333,484
- Share change
- +2,981,984
- SEC-reported price per share
- $23.50
- Number of holders
- 68
- Value change
- +$70,385,573
- Number of buys
- 50
- Number of sells
- 5
- Shares outstanding
- 46,795,294
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
68
Top holders
10
AVBP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
ArriVent BioPharma, Inc. SEC filings
ArriVent BioPharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04272N102
Recent filing periods:
Ownership snapshot
Top reported holders of AVBP - ArriVent BioPharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
HHLR ADVISORS, LTD.
Disclosed value leader
HHLR ADVISORS, LTD.
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
3/4/5
Lead comparable stake: 9.6%
Showing 1-6 of 15 holder rows.
Quick read
HHLR ADVISORS, LTD. leads the comparable SEC ownership view at 9.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens HHLR ADVISORS, LTD.'s linked filing trail.
Comparable ownership
Top 5
HHLR ADVISORS, LTD.
9.6%
ORBIMED ADVISORS LLC
6.5%
FMR LLC
4.2%
Octagon Capital Advisors LP
3.9%
SUVRETTA CAPITAL MANAGEMENT, LLC
3.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. |
13F
Company
|
9.6%
|
$83,190,666
4,484,672 shares
|
— | 30 Jun 2024 |
| ORBIMED ADVISORS LLC |
13F
3/4/5
Company · Director, 10%+ Owner
|
6.5%
|
$56,156,934
3,027,328 shares
|
— | 30 Jun 2024 |
| FMR LLC |
13F
Company
|
4.2%
|
$36,175,858
1,950,181 shares
|
— | 30 Jun 2024 |
| Octagon Capital Advisors LP |
13F
Company
|
3.9%
|
$33,451,289
1,803,304 shares
|
— | 30 Jun 2024 |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
Company
|
3.7%
|
$31,770,641
1,712,703 shares
|
— | 30 Jun 2024 |
| Sofinnova Investments, Inc. |
13F
Company
|
3.6%
|
$31,474,750
1,696,752 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
68
Shares
25,909,614
Rows available
68
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
53
Q3 2024 holders
68
Holder diff
15
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend